BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yun UJ, Lee JH, Koo KH, Ye SK, Kim SY, Lee CH, Kim YN. Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition. Biochem Pharmacol 2013;85:1441-53. [PMID: 23473805 DOI: 10.1016/j.bcp.2013.02.025] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhang S, Zhu N, Li HF, Gu J, Zhang CJ, Liao DF, Qin L. The lipid rafts in cancer stem cell: a target to eradicate cancer. Stem Cell Res Ther 2022;13:432. [PMID: 36042526 DOI: 10.1186/s13287-022-03111-8] [Reference Citation Analysis]
2 Yun U, Bae S, Song Y, Kim Y. A Critical YAP in Malignancy of HCC Is Regulated by Evodiamine. IJMS 2022;23:1855. [DOI: 10.3390/ijms23031855] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Loh D, Reiter RJ. Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance. Molecules 2022;27:705. [PMID: 35163973 DOI: 10.3390/molecules27030705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Xu JF, Wan Y, Tang F, Chen L, Yang Y, Xia J, Wu JJ, Ao H, Peng C. Emerging Significance of Ginsenosides as Potentially Reversal Agents of Chemoresistance in Cancer Therapy. Front Pharmacol 2021;12:720474. [PMID: 34975466 DOI: 10.3389/fphar.2021.720474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zeng X, Li Z, Zhu C, Xu L, Sun Y, Han S. Research progress of nanocarriers for gene therapy targeting abnormal glucose and lipid metabolism in tumors. Drug Deliv 2021;28:2329-47. [PMID: 34730054 DOI: 10.1080/10717544.2021.1995081] [Reference Citation Analysis]
6 Elekofehinti OO, Iwaloye O, Olawale F, Ariyo EO. Saponins in Cancer Treatment: Current Progress and Future Prospects. Pathophysiology 2021;28:250-72. [PMID: 35366261 DOI: 10.3390/pathophysiology28020017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
7 D'Aprile C, Prioni S, Mauri L, Prinetti A, Grassi S. Lipid rafts as platforms for sphingosine 1-phosphate metabolism and signalling. Cell Signal 2021;80:109929. [PMID: 33493577 DOI: 10.1016/j.cellsig.2021.109929] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wu J, Niu S, Li G, Tian Q, Xiang Y. Antitumor Effect of Ginsenosides: A Systematic Review. YM 2021;05:207-25. [DOI: 10.4236/ym.2021.53020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Verstraeten SL, Lorent JH, Mingeot-Leclercq MP. Lipid Membranes as Key Targets for the Pharmacological Actions of Ginsenosides. Front Pharmacol 2020;11:576887. [PMID: 33041822 DOI: 10.3389/fphar.2020.576887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Duan L, Li M, Wang F, Cai Y, Li H, Zhou W, Li Y, Chen Q, Bai J, Liu H. Increased Risk of Clopidogrel-Induced Gastric Mucosal Erosion in Elderly Chinese Men Harboring the ABCB1 3435T Allele. Risk Manag Healthc Policy 2020;13:1237-44. [PMID: 32904459 DOI: 10.2147/RMHP.S263625] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Yan YB, Tian Q, Zhang JF, Xiang Y. Antitumor effects and molecular mechanisms of action of natural products in ovarian cancer. Oncol Lett 2020;20:141. [PMID: 32934709 DOI: 10.3892/ol.2020.12001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
12 Bailly C, Vergoten G. Proposed mechanisms for the extracellular release of PD-L1 by the anticancer saponin platycodin D. Int Immunopharmacol 2020;85:106675. [PMID: 32531711 DOI: 10.1016/j.intimp.2020.106675] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
13 Yun UJ, Lee IH, Lee JS, Shim J, Kim YN. Ginsenoside Rp1, A Ginsenoside Derivative, Augments Anti-Cancer Effects of Actinomycin D via Downregulation of an AKT-SIRT1 Pathway. Cancers (Basel) 2020;12:E605. [PMID: 32151067 DOI: 10.3390/cancers12030605] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
14 Guzmán-Flores JE, Steinemann-Hernández L, González de la Vara LE, Gavilanes-Ruiz M, Romeo T, Alvarez AF, Georgellis D. Proteomic analysis of Escherichia coli detergent-resistant membranes (DRM). PLoS One 2019;14:e0223794. [PMID: 31603938 DOI: 10.1371/journal.pone.0223794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
15 Hussain AA, Lee Y, Marshall J. Understanding the complexity of the matrix metalloproteinase system and its relevance to age-related diseases: Age-related macular degeneration and Alzheimer's disease. Prog Retin Eye Res 2020;74:100775. [PMID: 31473329 DOI: 10.1016/j.preteyeres.2019.100775] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
16 Yun UJ, Lee JH, Shim J, Yoon K, Goh SH, Yi EH, Ye SK, Lee JS, Lee H, Park J, Lee IH, Kim YN. Anti-cancer effect of doxorubicin is mediated by downregulation of HMG-Co A reductase via inhibition of EGFR/Src pathway. Lab Invest 2019;99:1157-72. [PMID: 30700846 DOI: 10.1038/s41374-019-0193-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
17 Li D, Fan Y, Shen M, Bányai I, Shi X. Design of dual drug-loaded dendrimer/carbon dot nanohybrids for fluorescence imaging and enhanced chemotherapy of cancer cells. J Mater Chem B 2019;7:277-85. [DOI: 10.1039/c8tb02723d] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
18 Marques-santos LF, Grassi G, Bergami E, Faleri C, Balbi T, Salis A, Damonte G, Canesi L, Corsi I. Cationic polystyrene nanoparticle and the sea urchin immune system: biocorona formation, cell toxicity, and multixenobiotic resistance phenotype. Nanotoxicology 2018;12:847-67. [DOI: 10.1080/17435390.2018.1482378] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
19 Yuan WQ, Zhang RR, Wang J, Ma Y, Li WX, Jiang RW, Cai SH. Asclepiasterol, a novel C21 steroidal glycoside derived from Asclepias curassavica, reverses tumor multidrug resistance by down-regulating P-glycoprotein expression. Oncotarget 2016;7:31466-83. [PMID: 27129170 DOI: 10.18632/oncotarget.8965] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
20 Lu Y, Yang Y, Liu Y, Hao Y, Zhang Y, Hu Y, Jiang L, Gong Y, Wu K, Liu Y. Upregulation of PAG1/Cbp contributes to adipose-derived mesenchymal stem cells promoted tumor progression and chemoresistance in breast cancer. Biochem Biophys Res Commun 2017;494:719-27. [PMID: 29079189 DOI: 10.1016/j.bbrc.2017.10.118] [Cited by in Crossref: 11] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
21 Xu M, Tang X, Guo J, Sun W, Tang F. Reversal effect of adenovirus-mediated human interleukin 24 transfection on the cisplatin resistance of A549/DDP lung cancer cells. Oncol Rep 2017;38:2843-51. [PMID: 29048638 DOI: 10.3892/or.2017.6002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
22 Lin LF, Wu MH, Pidugu VK, Ho IC, Su TL, Lee TC. P-glycoprotein attenuates DNA repair activity in multidrug-resistant cells by acting through the Cbp-Csk-Src cascade. Oncotarget 2017;8:45072-87. [PMID: 28178691 DOI: 10.18632/oncotarget.15065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
23 Vesel M, Rapp J, Feller D, Kiss E, Jaromi L, Meggyes M, Miskei G, Duga B, Smuk G, Laszlo T, Karner I, Pongracz JE. ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling. Respir Res. 2017;18:52. [PMID: 28340578 DOI: 10.1186/s12931-017-0537-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 49] [Article Influence: 6.6] [Reference Citation Analysis]
24 Mao X, Si J, Huang Q, Sun X, Zhang Q, Shen Y, Tang J, Liu X, Sui M. Self-Assembling Doxorubicin Prodrug Forming Nanoparticles and Effectively Reversing Drug Resistance In Vitro and In Vivo. Adv Healthc Mater 2016;5:2517-27. [PMID: 27529558 DOI: 10.1002/adhm.201600345] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
25 Wang W, Lv M, Wang Y, Zhang J. Development of novel application of 3,3′-diindolylmethane: sensitizing multidrug resistance human breast cancer cells to γ-irradiation. Pharmaceutical Biology 2016;54:3164-8. [DOI: 10.1080/13880209.2016.1192198] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
26 Thakur PS, Khan AM, Talegaonkar S, Ahmad FJ, Iqbal Z. Hurdles in selection process of nanodelivery systems for multidrug-resistant cancer. J Cancer Res Clin Oncol 2016;142:2073-106. [PMID: 27116692 DOI: 10.1007/s00432-016-2167-7] [Reference Citation Analysis]
27 Ferreira RJ, dos Santos DJ, Ferreira MU. P-glycoprotein and membrane roles in multidrug resistance. Future Medicinal Chemistry 2015;7:929-46. [DOI: 10.4155/fmc.15.36] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 6.7] [Reference Citation Analysis]
28 Zhang Y, Qu X, Li C, Fan Y, Che X, Wang X, Cai Y, Hu X, Liu Y. miR-103/107 modulates multidrug resistance in human gastric carcinoma by downregulating Cav-1. Tumour Biol. 2015;36:2277-2285. [PMID: 25407491 DOI: 10.1007/s13277-014-2835-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 52] [Article Influence: 5.5] [Reference Citation Analysis]
29 Park JI, Bae HR, Kim CG, Stonik VA, Kwak JY. Relationships between chemical structures and functions of triterpene glycosides isolated from sea cucumbers. Front Chem 2014;2:77. [PMID: 25250309 DOI: 10.3389/fchem.2014.00077] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
30 Kim MY, Yoo BC, Cho JY. Ginsenoside-Rp1-induced apolipoprotein A-1 expression in the LoVo human colon cancer cell line. J Ginseng Res 2014;38:251-5. [PMID: 25379004 DOI: 10.1016/j.jgr.2014.06.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]